Literature DB >> 15740082

Secondary metabolite and mycotoxin production by the Rhizopus microsporus group.

Jennifer Jennessen1, Kristian Fog Nielsen, Jos Houbraken, Ellen Kirstine Lyhne, Johan Schnürer, Jens Christian Frisvad, Robert A Samson.   

Abstract

Fast-growing Zygomycetes, most notably Rhizopus oligosporus, are traditionally used in many food fermentations, for example, for soybean tempeh production. R. oligosporus is considered to belong to the Rhizopus microsporus group. Certain R. microsporus strains have been reported to produce either the pharmaceutically active rhizoxins or the highly toxic rhizonins A and B. In this study was investigated the formation of secondary metabolites by R. microsporus, R. oligosporus, and Rhizopus chinensis grown on a wide range of different semisynthetic and natural substrates. Liquid chromatography, combined with photodiode array detection and high-resolution mass spectrometric techniques, was used to identify secondary metabolites. Growth on maize, brown rice, and Pharma agar gave both the highest amounts and the maximum diversity of rhizoxins and rhizonins. Rhizoxins were produced by all four R. microsporus strains, whereas only one strain produced rhizonins. The six R. oligosporus and four R. chinensis strains investigated did not produce any of these two classes of metabolites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15740082     DOI: 10.1021/jf048147n

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  13 in total

1.  Investigation of presence of endofungal bacteria in Rhizopus spp. ısolated from the different food samples.

Authors:  Derya Birol; Ozlem Abaci Gunyar
Journal:  Arch Microbiol       Date:  2021-02-27       Impact factor: 2.552

Review 2.  Pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

3.  Future directions in mucormycosis research.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis; Oliver Lortholary; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roilides; Emmanuel Roillides; Ashraf Ibrahim; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

4.  Rhizonin, the first mycotoxin isolated from the zygomycota, is not a fungal metabolite but is produced by bacterial endosymbionts.

Authors:  Laila P Partida-Martinez; Carina Flores de Looss; Keishi Ishida; Mie Ishida; Martin Roth; Katrin Buder; Christian Hertweck
Journal:  Appl Environ Microbiol       Date:  2006-11-22       Impact factor: 4.792

5.  Illumina-Based Analysis Yields New Insights Into the Fungal Contamination Associated With the Processed Products of Crataegi Fructus.

Authors:  Jingsheng Yu; Mengyue Guo; Wenjun Jiang; Yujie Dao; Xiaohui Pang
Journal:  Front Nutr       Date:  2022-05-12

6.  Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Teclegiorgis Gebremariam; Mingfu Liu; Georgios Chamilos; Dimitrios Kontoyiannis; Richard Mink; Kyung J Kwon-Chung; Yue Fu; Christopher D Skory; John E Edwards; Brad Spellberg
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

7.  Detection of 3-nitropropionic acid and cytotoxicity inMucor circinelloides.

Authors:  M Hollmann; E Razzazi-Fazeli; J Grajewski; M Twaruzek; M Sulyok; J Böhm
Journal:  Mycotoxin Res       Date:  2008-09       Impact factor: 3.833

Review 8.  Review on Mycotoxin Issues in Ruminants: Occurrence in Forages, Effects of Mycotoxin Ingestion on Health Status and Animal Performance and Practical Strategies to Counteract Their Negative Effects.

Authors:  Antonio Gallo; Gianluca Giuberti; Jens C Frisvad; Terenzio Bertuzzi; Kristian F Nielsen
Journal:  Toxins (Basel)       Date:  2015-08-12       Impact factor: 4.546

9.  Gastric perforation after duodenopancreatectomy.

Authors:  Henrik Bäcker; Frank Jp Beeres; Marco Rossi; Andreas Scheiwiller
Journal:  Med Mycol Case Rep       Date:  2017-07-27

Review 10.  An Overview of Metabolic Activity, Beneficial and Pathogenic Aspects of Burkholderia Spp.

Authors:  Hazem S Elshafie; Ippolito Camele
Journal:  Metabolites       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.